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Visceral vessel relocation techniques
Mark A. Farber, MD, Chapel Hill, NCIt has been more than a decade since the first implan-
tation of a thoracic stent graft was reported, and only
recently has the first device been approved by the Food and
Drug Administration.1,2 Even though the technology has
been approved by the Food and Drug Administration for 5
years for infrarenal aneurysmal repair, devices for use in the
thoracic aorta are considered first generation and are lim-
ited by constraints similar to those that infrarenal devices
are subject to. Additionally, complicated devices that allow
for fenestration or branched designs are lacking or are only
in the initial phases of development.3
Providing adequate distal fixation and accomplishing
aneurysm exclusion with an appropriate sealing region is
the most challenging task in many patients.4 Almost all
infrarenal devices require 1.5 cm of aortic neck length to
provide adequate fixation and seal for aneurysmal exclu-
sion. Additional length is needed in the thoracic aorta,
however, given its larger size; 2.0 to 3.0 cm is generally
thought to be sufficient. Some experts rely on a ratio
calculation and target a fixation length of 0.75 times the
aortic diameter as a minimal acceptable length. It is also
crucial that the aortic walls be fairly parallel and free of
significant calcification and thrombus. Although isolated
thoracic aortic lesions can still meet these requirements,
many thoracic aortic processes involve the entire descend-
ing thoracic aorta and end at, or near, the crus of the
diaphragm or in the visceral section. In these cases, obtain-
ing adequate fixation can be problematic. The angle of the
descending thoracic aorta also plays a major role in the
migration of thoracic stent grafts, possibly causing a ceph-
alad migration of the caudal aspect of the device. It can also
make precise deployment rather difficult; many times it is
necessary to deploy an additional distal extension.5 Im-
planting the device in a region where significant angulation
exists can jeopardize the durability of the endovascular
repair. Finally, most stent graft deploymentmechanisms are
designed for precise proximal placement with minimal or
no control over the distal attachment site or landing zone.
Therefore, accurate deployment near the celiac artery be-
comes more challenging. Given the aforementioned issues,
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aortic debranching techniques in a small but not insignifi-
cant number of patients.
Although additional fixation can be obtained on the
proximal aspect of the aneurysm by either carotid subcla-
vian bypass or coverage of the left subclavian artery, the
visceral section of the aorta is less forgiving. Although there
are reports of celiac artery coverage without incident, severe
complications may arise from either hepatic or splenic
ischemia, resulting in the potential demise of the patient.6,7
It has been our approach to routinely revascularize all celiac
arteries if coverage is planned unless certain contraindica-
tions exist. These include prohibitive abdominal surgical
risks, a diminutive hepatic or inflow vessel that may poten-
tially jeopardize collateral flow, or documented celiac artery
occlusion. In patients who have a replaced right hepatic
artery originating from the superior mesenteric artery
(SMA), adequate collateral flow may exist to the liver.
Documentation of adequate gastric and splenic flow is,
however, still recommended.
Initial reports of hybrid procedures have described
promising results.8-14 Before performing visceral proce-
dures, it is important to evaluate the hemodynamic and
anatomic status of the visceral section, including both renal
arteries. Because most patients undergo detailed imaging
with either magnetic resonance imaging or computed to-
mography for diagnosis, many of the anatomic aspects
usually are already identified. If, however, any questions
about the anatomy arise, visceral angiography can be per-
formed. For hemodynamic evaluation we have relied on
duplex ultrasonography, which has a high degree of accu-
racy when performed in experienced peripheral vascular
laboratories. Once these studies have been completed, ap-
propriate inflow vessels can be identified, and the baseline
status of the patient can be documented.
CELIAC ARTERY DEBRANCHING
In patients who require only a short amount of length-
ening of the distal landing zone, one of three techniques
can be used: celiac coil embolization, renohepatic bypass,
or celiac revascularization from the aortoiliac region. Al-
though renosplenic bypass could be performed, it has never
been reported in the literature. In patients being evaluated
for celiac coil embolization, consideration must be given to
the preservation of splenic function. Prior reports of splenic
artery embolization have documented preservation of im-
munoprotective function in patients through collaterals
and the short gastrics.15,16 However, these have been per-
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cesses. The likelihood of preserved protection may be re-
duced in patients with aneurysmal disease, given the
reduced number of intercostals and the disease process.
Appropriate vaccines should therefore be given before the
procedure if there is any potential for the loss of splenic
function. Additionally, it is important to document the
collateral circulation from the SMA to the liver before coil
embolization.
As mentioned previously, severe complications have
been reported when the celiac artery has been acutely
occluded.6,7 To help preserve collateral flow after emboli-
zation, all efforts should be made to place the coils only in
the main celiac trunk. In isolated cases where the aneurysm
ends above the celiac artery and the stent graft will abut the
orifice of the celiac artery, coil embolization may not be
necessary, because the device will perform the same func-
tion as coils placed in the artery. However, caution is
advised in this situation: if a type II endoleak from the celiac
artery occurs after the deployment of the stent graft, access
is extremely limited, if not impossible, via endovascular
means.
Celiac artery revascularization can be achieved from
several approaches, of which the renohepatic bypass is
probably the most simple and well tolerated. Designed
primarily to treat renal occlusive disease before endovascu-
Fig 1. Renohepatic bypass and thoracic endograft exclusion of a
thoracic aneurysm.lar techniques, the bypass procedure can used in reversefashion (Fig 1). Most procedures are performed through a
subcostal incision, although a midline celiotomy can be
used if necessary. The hepatic artery is identified through
the lesser omentum. Control and anastomosis proximal to
the gastroduodenal artery (GDA) is ideal, although not
always possible. After a Kocher maneuver is performed, the
inferior vena cava, right renal vein, and right renal artery are
identified and dissected. Additionally, the celiac artery
should be dissected before heparinization so that it may be
ligated at the completion of the procedure. An appropriate
conduit, either autologous or synthetic, should be chosen
to match the target vessel diameters. Many surgeons prefer
the autologous saphenous vein when treating patients with
occlusive renal disease, because it may impart a greater
long-term patency. This concern has not been documented
in the treatment of patients without occlusive disease. After
systemic heparinization, the side-to-end renal anastomosis
is usually performed first, followed by the hepatic artery
reconstruction in an end-to-side fashion. Generally the
bypass follows a gentle curved “C” configuration. If
needed, an end-to-end anastomosis can be performed to
the GDA. Caution should be taken when the GDA is used,
because it provides important mesenteric collateral flow
should complications arise with the bypass. Once the by-
pass is completed and satisfactory flow is established, the
celiac artery should be ligated at its origin to avoid the
potential for subsequent type II endoleak.
When renal artery disease precludes usage of the renal
artery as an inflow source, retrograde bypass can be per-
formed from the aortoiliac segment. Antegrade bypasses
(supraceliac or descending thoracic aorta) are generally not
possible, given the proximity of the aneurysm to the visceral
section. However, it should be noted that in type IV thoraco-
abdominal aortic aneurysms, antegrade bypass techniques can
serve as ameans for visceral debranching to provide an avenue
for endovascular repair in selected patients.
In patients for whom the infrarenal aorta will be used
as the inflow source, several considerations exist. Patients
with thoracic aneurysms may develop extension of their
disease to the infrarenal aorta, thereby involving the
inflow site, or the infrarenal aorta may contain significant
atherosclerotic disease, thus affecting the durability of the
bypass. Some surgeons therefore use the iliac arteries as
inflow sources. In this scenario, passage of the thoracic
endograft past the inflow bypass graft should be avoided,
and the contralateral iliac should be used for endovascular
graft deployment. If this is not possible, then consideration
should be given to a simultaneous iliac conduit. In either
situation, the bypass is tunneled in a retropancreatic fashion
and anastomosed to the celiac artery. Prosthetic conduits
are generally used in this situation, given their longer
length.
SMA RECONSTRUCTIONS
In a large number of patients, the celiac and SMA are
located in proximity to one another, and both vessels must
be relocated to ensure adequate neck length. A transab-
dominal approach is required for adequate exposure. The
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previous aortic surgery or the extent of aneurysmal or
occlusive disease. When infrarenal aneurysmal disease is
concomitant, the location of the iliac donor site is critical: if
future endovascular repair of abdominal aortic aneurysm is
planned, then the bypass may need to originate from either
the very distal common iliac or external iliac artery, depend-
ing on their individual lengths and the extent of disease
involvement. Either bifurcated or individual grafts can be
constructed, depending on the anatomy. The celiac artery
limb is tunneled much as described previously, and the
SMA limb placed in a lazy “C” configuration.
COMPLETE VISCERAL REVASCULARIZATION
On occasion, the entire visceral section must be revascu-
larized. Inflow source, celiac artery, and SMA considerations
are identical to those already mentioned. In addition, prefab-
ricated Dacron (DuPont, Wilmington, Del) branched grafts
can be used. Each renal artery should be considered sepa-
rately. For the left renal artery, three options exist: spleno-
renal bypass, iliorenal bypass, or attachment to one limb of
the celiac or SMA reconstruction. The right renal artery
similarly can be managed with a heporenal bypass, iliorenal
bypass, or attachment to the visceral reconstruction limb.
The method for iliorenal bypass has been described previ-
ously and involves an end-to-side anastomosis to the infe-
rior aspect of the renal artery.8 Either prosthetic or autolo-
gous bypass can be performed and generally tunneled
underneath the ureter.
SPECIAL CONSIDERATIONS
Type IV thoracoabdominal aortic aneurysms merit spe-
cial mention. Because visceral involvement is associated
with proximal attachment site issues, additional options
should be considered. Descending thoracic aorta recon-
struction can be performed that allows for complete visceral
debranching, because only partial occlusion clamps are
used and the procedure is well tolerated.8 This process is
achieved through two stages. The first stage consists of a
thoracoceliac, thoracomesenteric, and left renal bypass.
The patient is positioned in the right lateral decubitus
orientation after intubation with a double-lumen endotra-
cheal tube. A bean bag and axillary roll are routinely re-
quired to aid in positioning. A ninth-interspace thoracoret-
roperitoneal incision is used to expose the thoracic and
upper abdominal aorta (Fig 2). Mobilization of the perito-
neum and its contents from the undersurface of the dia-
phragm is performed bluntly. The diaphragm is incised in a
curvilinear fashion 2 cm from its costal edge to preserve
innervation and with marking stitches to facilitate reap-
proximation. The inferior pulmonary ligament is divided,
as well as the crus of the diaphragm. The celiac and superior
mesenteric vessels are exposed until a suitable bypass graft
site is obtained. The left kidney is undisturbed in its native
position to facilitate distal exposure of the SMA. A partial
occlusion clamp technique is used to maintain distal aortic
flow to the kidneys and spinal cord. The proximal anasto-
moses are performed with a single clamp application tominimize repeated trauma to the thoracic aorta. Prosthetic
bypass graft conduits are used and routed through the
diaphragmatic hiatus to their respective vessels in an end-
to-side fashion to establish antegrade flow. We typically use
two separate grafts for mesenteric bypass. In our opinion,
this allows greater freedom in graft orientation, although a
bifurcated graft is an acceptable alternative. Revasculariza-
tion of the left kidney is accomplished with a bypass graft
from the thoracomesenteric graft to the left renal artery.
The second stage of the repair consists of a bypass graft
from the right external iliac artery to the right renal artery
through a retroperitoneal exposure and endovascular ab-
dominal aortic aneurysm repair to provide complete exclu-
sion of the aneurysm (Fig 3). In all reconstructions, the
proximal portion of the reconstructed vessels is ligated to
prevent type II endoleak after endovascular repair.
The descending thoracic aorta is relatively free of ath-
erosclerotic disease. Thoracoretroperitoneal revasculariza-
Fig 2. Incision (ninth interspace) for thoracoabdominal revascu-
larization of the visceral arteries.tion provides several technical advantages. It allows for easy
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necessary, concomitant procedures can be performed for
renal and lower extremity revascularization. It is, however,
more difficult in patients who have undergone prior left
chest surgery. Because the descending thoracic aorta is
rarely diseased, only partial occlusion is required, thereby
reducing the potential for renal and spinal cord ischemia
associated with supraceliac clamping. Even in debilitated
patients, the incision is well tolerated.
CONCLUSION
Until branched and fenestrated endograft techniques
become widely distributed, hybrid surgery will be necessary
to reduce the major morbidity and mortality associated
Fig 3. Thoracoabdominal visceral revascularization and endovas-
cular repair of a type IV thoracoabdominal aortic aneurysm.with thoracoabdominal aneurysm repair. Because of thecomplexity of the disease and comorbid conditions en-
countered in this patient population, the approach to each
patient should be individualized, taking into account the
risks and benefits of all options, including open surgical
repair, observation, and hybrid procedures. Furthermore,
the potential need for future procedures and plans should
be considered thoroughly.
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